Pipeline · Bill → Law
Step 1
Introduced
Apr 21, 2021
Step 2
Referred
Oct 19, 2021
E&C · Judiciary · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available
No CRS summary available for this bill.
15 provisions
5 provisions
5 provisions
1 provision
4 provisions
7 provisions
7 provisions
5 provisions
1 provision
1 provision
1 provision
9 provisions
Similar Bills · 1 matches
| Bill | Text overlap | Status |
|---|---|---|
| S. 164— Advancing Education on Biosimilars Act of 2021 | 97% | ENACTED |
Timeline · 7 actions
Oct 19, 2021
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Apr 22, 2021
Referred to the Subcommittee on Health.
Apr 21, 2021
Introduced in House
Apr 21, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 21, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 21, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 21, 2021
Referred to the Subcommittee on Health.